Alimera Sciences (ALIM)
(Delayed Data from NSDQ)
$2.95 USD
-0.04 (-1.34%)
Updated May 24, 2024 04:00 PM ET
After-Market: $2.93 -0.02 (-0.68%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
ALIM 2.95 -0.04(-1.34%)
Will ALIM be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ALIM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ALIM
Alimera Sciences (ALIM) Reports Q1 Loss, Misses Revenue Estimates
New Strong Sell Stocks for March 13th
ALIM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alimera Sciences (ALIM) Reports Q4 Loss, Tops Revenue Estimates
Novavax (NVAX) Reports Q4 Loss, Lags Revenue Estimates
Alimera Sciences (ALIM) Reports Q3 Loss, Misses Revenue Estimates
Other News for ALIM
Robust Growth and Promising Trials: Buy Rating for Alimera Sciences
Alimera Sciences: A Strong Buy on Robust Q1 Growth, Strategic Acquisitions, and Positive Financial Indicators
Alimera Sciences Inc (ALIM) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and ...
Alimera Sciences, Inc. (ALIM) Q1 2024 Earnings Call Transcript
ALIM Stock Earnings: Alimera Sciences Misses EPS, Beats Revenue for Q1 2024